Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.110
0.00 (0.00%)
At close: Nov 26, 2025, 4:00 PM EST
1.150
+0.040 (3.60%)
After-hours: Nov 26, 2025, 7:46 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $24.85 million as of November 26, 2025. Its market cap has decreased by -66.44% in one year.
Market Cap
24.85M
Enterprise Value
-42.96M
1-Year Change
-66.44%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $24.85M, a decrease of -93.02%. That is a compound annual growth rate of -79.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 24.85M | -61.58% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |